Psychobiotics: The Next-Generation Probiotics for the Brain

Area of Science:

• Microbiology
• Neuroscience
• Gastroenterology

Background:

• Psychobiotics represent a specialized category of probiotics.
• They possess the unique ability to produce or stimulate neurotransmitters, short-chain fatty acids, enteroendocrine hormones, and anti-inflammatory cytokines.
• These actions differentiate them from conventional probiotics.

Purpose of the Study:

• To review the scope and advancements in psychobiotics.
• To highlight their potential applications in mental and neurological health.
• To discuss current market products and associated concerns.

Main Methods:

• Literature review of scientific publications on psychobiotics.
• Analysis of the mechanisms of action involving the gut-brain axis.
• Examination of commercial psychobiotic products and market trends.

Main Results:

• Psychobiotics influence the gut-brain axis through neurochemical signaling.
• They show potential in mood and stress management, and as adjunct therapy for neurodevelopmental and neurodegenerative disorders.
• Common psychobiotic bacteria include species from Lactobacilli, Streptococci, Bifidobacteria, Escherichia, and Enterococci.

Conclusions:

• Psychobiotics offer a promising avenue for mental health support via the gut-brain axis.
• Potential applications span mood regulation to therapeutic interventions for neurological conditions.
• Concerns regarding withdrawal effects, immunocompromised individuals, and market regulation need careful consideration.